Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow Reinvestment Rate
Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow Reinvestment Rate of 0.44x as of March 2026, reinvesting ₩1.99 Billion (capex ₩197.80 Million plus investments ₩-1.79 Billion) from operating cash flow of ₩4.53 Billion. See free cash flow generation of Jin Yang Pharmaceutical Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jin Yang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Jin Yang Pharmaceutical Co. Ltd across 8 annual periods. For the full cash flow conversion analysis, see Jin Yang Pharmaceutical Co. Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Jin Yang Pharmaceutical Co. Ltd (2018–2025)
Year-by-year capital reinvestment analysis for Jin Yang Pharmaceutical Co. Ltd. See how financially flexible is Jin Yang Pharmaceutical Co. Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.67x | ₩3.92 Billion | ₩1.46 Billion | ₩3.67 Billion | ▼ -60.8% |
| 2024 | 6.82x | ₩87.22 Billion | ₩12.79 Billion | ₩947.22 Million | ▲ +1120.0% |
| 2023 | 0.56x | ₩4.77 Billion | ₩8.53 Billion | ₩1.53 Billion | ▼ -62.7% |
| 2022 | 1.50x | ₩11.17 Billion | ₩7.45 Billion | ₩3.22 Billion | ▼ -26.9% |
| 2021 | 2.05x | ₩4.04 Billion | ₩1.97 Billion | ₩2.52 Billion | ▲ +191.0% |
| 2020 | 0.71x | ₩4.41 Billion | ₩6.24 Billion | ₩1.36 Billion | ▲ +198.1% |
| 2019 | 0.24x | ₩1.71 Billion | ₩7.21 Billion | ₩736.71 Million | ▼ -41.7% |
| 2018 | 0.41x | ₩429.64 Million | ₩1.06 Billion | ₩327.39 Million | — |